Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. Export

@article{citeulike:4139684, abstract = {BACKGROUND: Thin glomerular basement membrane disease (TBMD) is a nephropathy defined by diffuse thinning of the glomerular basement membrane (GBM) at electron microscopy examination, without the alterations of Alport's syndrome (ATS). It is known that many patients with TBMD have a type IV collagen disorder and that the disease occasionally may be progressive. This study investigated 51 patients with the morphological diagnosis of TBMD lacking any sign of ATS, with the aim of defining the prevalence of type IV collagen mutations and the course of the disease. METHODS: Patients were investigated as follows: (a) clinical picture and family investigation; (b) renal biopsy findings; (c) immunohistochemical study of renal tissue for collagen IV alpha-chains; (d) pedigree reconstruction and molecular investigations in genes encoding type IV collagen chains, when DNA samples were available; and (e) follow-up data. RESULTS: Renal biopsy analysis revealed no light microscopy changes in 27 patients and minimal abnormalities in the remainder. Global glomerular sclerosis was found in seven cases and superimposed mesangial immunoglobulin-A deposits in four. Normal staining of GBM for alpha(IV) chains was observed in all but one patient, where alpha5(IV) was absent and molecular investigation revealed a COL4A5 mutation. Five out of 25 cases had a mutation in the COL4A3/COL4A4 genes. Eight out of 38 patients followed up for 12-240 months (21\%) showed signs of disease progression or hypertension. CONCLUSIONS: This study confirms that a considerable proportion of patients with TBMD have a type IV collagen disorder and that this lesion is not always benign. Thus, families should be investigated carefully whenever possible and patients and affected relatives should be examined periodically for signs of disease progression.}, author = {Frasc\`{a}, G. M. and Onetti-Muda, A. and Mari, F. and Longo, I. and Scala, E. and Pescucci, C. and Roccatello, D. and Alpa, M. and Coppo, R. and Li Volti, G. and Feriozzi, S. and Bergesio, F. and Schena, F. P. and Renieri, A. and {}}, citeulike-article-id = {4139684}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/15618242}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=15618242}, issn = {0931-0509}, journal = {Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}, keywords = {transplant-living-donation}, month = {March}, number = {3}, pages = {545--551}, posted-at = {2009-03-06 01:40:42}, priority = {2}, title = {Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/15618242}, volume = {20}, year = {2005} }

TY - JOUR ID - citeulike:4139684 L3 - citeulike-article-id:4139684 N2 - BACKGROUND: Thin glomerular basement membrane disease (TBMD) is a nephropathy defined by diffuse thinning of the glomerular basement membrane (GBM) at electron microscopy examination, without the alterations of Alport's syndrome (ATS). It is known that many patients with TBMD have a type IV collagen disorder and that the disease occasionally may be progressive. This study investigated 51 patients with the morphological diagnosis of TBMD lacking any sign of ATS, with the aim of defining the prevalence of type IV collagen mutations and the course of the disease. METHODS: Patients were investigated as follows: (a) clinical picture and family investigation; (b) renal biopsy findings; (c) immunohistochemical study of renal tissue for collagen IV alpha-chains; (d) pedigree reconstruction and molecular investigations in genes encoding type IV collagen chains, when DNA samples were available; and (e) follow-up data. RESULTS: Renal biopsy analysis revealed no light microscopy changes in 27 patients and minimal abnormalities in the remainder. Global glomerular sclerosis was found in seven cases and superimposed mesangial immunoglobulin-A deposits in four. Normal staining of GBM for alpha(IV) chains was observed in all but one patient, where alpha5(IV) was absent and molecular investigation revealed a COL4A5 mutation. Five out of 25 cases had a mutation in the COL4A3/COL4A4 genes. Eight out of 38 patients followed up for 12-240 months (21%) showed signs of disease progression or hypertension. CONCLUSIONS: This study confirms that a considerable proportion of patients with TBMD have a type IV collagen disorder and that this lesion is not always benign. Thus, families should be investigated carefully whenever possible and patients and affected relatives should be examined periodically for signs of disease progression. IS - 3 JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association SN - 0931-0509 EP - 551 TI - Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. VL - 20 SP - 545 KW - transplant-living-donation AU - Frascà, GM AU - Onetti-Muda, A AU - Mari, F AU - Longo, I AU - Scala, E AU - Pescucci, C AU - Roccatello, D AU - Alpa, M AU - Coppo, R AU - Li Volti, G AU - Feriozzi, S AU - Bergesio, F AU - Schena, FP AU - Renieri, A PY - 2005/03// UR - http://view.ncbi.nlm.nih.gov/pubmed/15618242 ER -